ICVTS on-line discussion A. The safety of using millimolar doses of lidocaine as cardioplegia

Interact Cardiovasc Thorac Surg. 2007 Apr;6(2):176. doi: 10.1510/icvts.2006.137240A.
No abstract available

Publication types

  • Comment

MeSH terms

  • Animals
  • Cardioplegic Solutions / chemistry
  • Cardioplegic Solutions / pharmacology*
  • Cardioplegic Solutions / therapeutic use
  • Cardiopulmonary Bypass / adverse effects*
  • Edema, Cardiac / etiology
  • Edema, Cardiac / physiopathology
  • Edema, Cardiac / prevention & control*
  • Heart Arrest, Induced / methods*
  • Humans
  • Lidocaine / blood
  • Lidocaine / pharmacology*
  • Lidocaine / therapeutic use
  • Magnesium Compounds / pharmacology
  • Potassium Compounds / pharmacology
  • Research Design
  • Sodium Channel Blockers / blood
  • Sodium Channel Blockers / pharmacology*
  • Sodium Channel Blockers / therapeutic use
  • Time Factors
  • Ventricular Function, Left / drug effects*

Substances

  • Cardioplegic Solutions
  • Magnesium Compounds
  • Potassium Compounds
  • Sodium Channel Blockers
  • Lidocaine